ID   ACHB4_RAT               Reviewed;         495 AA.
AC   P12392; Q63361;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   02-OCT-2024, entry version 193.
DE   RecName: Full=Neuronal acetylcholine receptor subunit beta-4;
DE   AltName: Full=Neuronal acetylcholine receptor non-alpha-2 chain;
DE            Short=N-alpha 2;
DE   Flags: Precursor;
GN   Name=Chrnb4; Synonyms=Acrb4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   PubMed=2642007; DOI=10.1016/0896-6273(89)90207-9;
RA   Duvoisin R.M., Deneris E.S., Patrick J., Heinemann S.F.;
RT   "The functional diversity of the neuronal nicotinic acetylcholine receptors
RT   is increased by a novel subunit: beta 4.";
RL   Neuron 3:487-496(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM SHORT).
RX   PubMed=1689727; DOI=10.1016/s0021-9258(19)39588-2;
RA   Boulter J., O'Shea-Greenfield A., Duvoisin R.M., Connolly J.G., Wada E.,
RA   Jensen A., Gardner P.D., Ballivet M., Deneris E.S., McKinnon D.,
RA   Heinemann S.F., Patrick J.;
RT   "Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic
RT   acetylcholine receptor-related gene family form a gene cluster.";
RL   J. Biol. Chem. 265:4472-4482(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=Superior cervical ganglion;
RX   PubMed=2918319; DOI=10.1111/j.1471-4159.1989.tb02553.x;
RA   Isenberg K.E., Meyer G.E.;
RT   "Cloning of a putative neuronal nicotinic acetylcholine receptor subunit.";
RL   J. Neurochem. 52:988-991(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Groot-Kormelink P.J.;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   SUBUNIT, AND SITES LYS-81; ILE-133 AND GLN-141.
RX   PubMed=16964981; DOI=10.1021/bi0611715;
RA   Shiembob D.L., Roberts R.L., Luetje C.W., McIntosh J.M.;
RT   "Determinants of alpha-conotoxin BuIA selectivity on the nicotinic
RT   acetylcholine receptor beta subunit.";
RL   Biochemistry 45:11200-11207(2006).
CC   -!- FUNCTION: After binding acetylcholine, the AChR responds by an
CC       extensive change in conformation that affects all subunits and leads to
CC       opening of an ion-conducting channel across the plasma membrane.
CC   -!- SUBUNIT: Neuronal AChR is composed of two different types of subunits:
CC       alpha and beta. Beta-4 subunit can be combined to alpha-2, alpha-3 or
CC       alpha-4 to give rise to functional receptors. Interacts with RIC3;
CC       which is required for proper folding and assembly (By similarity).
CC       Interacts with LYPD6 (By similarity). The pentamer alpha3-beta-4
CC       interacts with the conotoxin BuIA (PubMed:16964981). The heteropentamer
CC       composed of alpha-3 and beta-4 subunits interacts with the alpha-
CC       conotoxin ImI (By similarity). {ECO:0000250|UniProtKB:P30926,
CC       ECO:0000269|PubMed:16964981}.
CC   -!- INTERACTION:
CC       P12392; P09483: Chrna4; NbExp=4; IntAct=EBI-9008856, EBI-7842410;
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane; Multi-pass membrane
CC       protein. Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Short;
CC         IsoId=P12392-1; Sequence=Displayed;
CC       Name=Long;
CC         IsoId=P12392-2; Sequence=VSP_000076;
CC   -!- TISSUE SPECIFICITY: In the brain, it is detected in the medial
CC       habenula. In the peripheral nervous system, it is found at least in the
CC       adrenal gland.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Acetylcholine receptor (TC 1.A.9.1) subfamily. Beta-4/CHRNB4 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U42976; AAA85212.1; -; mRNA.
DR   EMBL; M33953; AAA41668.1; -; Genomic_DNA.
DR   EMBL; J05232; AAA41668.1; JOINED; Genomic_DNA.
DR   EMBL; M89971; AAA41668.1; JOINED; Genomic_DNA.
DR   EMBL; M33951; AAA41668.1; JOINED; Genomic_DNA.
DR   EMBL; M89989; AAA41668.1; JOINED; Genomic_DNA.
DR   EMBL; M33952; AAA41668.1; JOINED; Genomic_DNA.
DR   EMBL; X15834; CAA33839.1; -; mRNA.
DR   EMBL; AY574260; AAS90356.1; -; mRNA.
DR   PIR; A30992; A30992.
DR   PIR; B35721; B35721.
DR   RefSeq; NP_434693.1; NM_052806.2. [P12392-1]
DR   AlphaFoldDB; P12392; -.
DR   SMR; P12392; -.
DR   ComplexPortal; CPX-183; Neuronal nicotinic acetylcholine receptor complex, alpha2-beta4.
DR   ComplexPortal; CPX-205; Neuronal nicotinic acetylcholine receptor complex, alpha3-beta4.
DR   ComplexPortal; CPX-208; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha5-beta4.
DR   ComplexPortal; CPX-211; Neuronal nicotinic acetylcholine receptor complex, alpha3-alpha6-beta4.
DR   ComplexPortal; CPX-219; Neuronal nicotinic acetylcholine receptor complex, alpha4-beta4.
DR   IntAct; P12392; 6.
DR   STRING; 10116.ENSRNOP00000019458; -.
DR   BindingDB; P12392; -.
DR   ChEMBL; CHEMBL2658; -.
DR   DrugCentral; P12392; -.
DR   GlyCosmos; P12392; 4 sites, No reported glycans.
DR   GlyGen; P12392; 4 sites.
DR   PhosphoSitePlus; P12392; -.
DR   PaxDb; 10116-ENSRNOP00000051052; -.
DR   Ensembl; ENSRNOT00000019458.6; ENSRNOP00000019458.2; ENSRNOG00000014427.8. [P12392-1]
DR   Ensembl; ENSRNOT00055054421; ENSRNOP00055044992; ENSRNOG00055031421. [P12392-1]
DR   Ensembl; ENSRNOT00060026550; ENSRNOP00060021229; ENSRNOG00060015498. [P12392-1]
DR   Ensembl; ENSRNOT00065031073; ENSRNOP00065024742; ENSRNOG00065018488. [P12392-1]
DR   GeneID; 25103; -.
DR   KEGG; rno:25103; -.
DR   UCSC; RGD:2351; rat. [P12392-1]
DR   AGR; RGD:2351; -.
DR   CTD; 1143; -.
DR   RGD; 2351; Chrnb4.
DR   eggNOG; KOG3645; Eukaryota.
DR   GeneTree; ENSGT00940000158708; -.
DR   HOGENOM; CLU_018074_1_1_1; -.
DR   InParanoid; P12392; -.
DR   OMA; PRQKPCN; -.
DR   OrthoDB; 5489962at2759; -.
DR   Reactome; R-RNO-629587; Highly sodium permeable postsynaptic acetylcholine nicotinic receptors.
DR   Reactome; R-RNO-629594; Highly calcium permeable postsynaptic nicotinic acetylcholine receptors.
DR   Reactome; R-RNO-629597; Highly calcium permeable nicotinic acetylcholine receptors.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:P12392; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000014427; Expressed in ovary and 8 other cell types or tissues.
DR   GO; GO:0005892; C:acetylcholine-gated channel complex; IDA:RGD.
DR   GO; GO:0098981; C:cholinergic synapse; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0042166; F:acetylcholine binding; IDA:RGD.
DR   GO; GO:0015464; F:acetylcholine receptor activity; ISO:RGD.
DR   GO; GO:0022848; F:acetylcholine-gated monoatomic cation-selective channel activity; ISO:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0035095; P:behavioral response to nicotine; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0051899; P:membrane depolarization; IBA:GO_Central.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; ISO:RGD.
DR   GO; GO:0035094; P:response to nicotine; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0006939; P:smooth muscle contraction; ISO:RGD.
DR   GO; GO:0060084; P:synaptic transmission involved in micturition; ISO:RGD.
DR   CDD; cd19064; LGIC_TM_nAChR; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF385; NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT BETA-4; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..495
FT                   /note="Neuronal acetylcholine receptor subunit beta-4"
FT                   /id="PRO_0000000391"
FT   TOPO_DOM        21..235
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        236..256
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        257..264
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        265..285
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        286..297
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        298..318
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        319..463
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        464..484
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        485..495
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   SITE            81
FT                   /note="Key residue that facilitates effective access of the
FT                   conotoxin BuIA to the channel binding site"
FT                   /evidence="ECO:0000305|PubMed:16964981"
FT   SITE            133
FT                   /note="Key residue for a low dissociation (K(off)) from the
FT                   conotoxin BuIA"
FT                   /evidence="ECO:0000305|PubMed:16964981"
FT   SITE            141
FT                   /note="Key residue for a low dissociation (K(off)) from the
FT                   conotoxin BuIA"
FT                   /evidence="ECO:0000305|PubMed:16964981"
FT   CARBOHYD        35
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        137
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        165
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        152..166
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         17
FT                   /note="D -> DARLFDCSGVLPDKGPAGLTVRFP (in isoform Long)"
FT                   /evidence="ECO:0000303|PubMed:2918319"
FT                   /id="VSP_000076"
FT   CONFLICT        9
FT                   /note="V -> VV (in Ref. 3; CAA33839)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="Missing (in Ref. 2; AAA41668)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230..231
FT                   /note="KP -> NA (in Ref. 2; AAA41668 and 3; CAA33839)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        287..288
FT                   /note="Missing (in Ref. 3; CAA33839)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        290
FT                   /note="D -> N (in Ref. 3; CAA33839)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   495 AA;  55861 MW;  688F37AB80448F7F CRC64;
     MRGTPLLLVS LFSLLQDGDC RLANAEEKLM DDLLNKTRYN NLIRPATSSS QLISIRLELS
     LSQLISVNER EQIMTTSIWL KQEWTDYRLA WNSSCYEGVN ILRIPAKRVW LPDIVLYNNA
     DGTYEVSVYT NVIVRSNGSI QWLPPAIYKS ACKIEVKHFP FDQQNCTLKF RSWTYDHTEI
     DMVLKSPTAI MDDFTPSGEW DIVALPGRRT VNPQDPSYVD VTYDFIIKRK PLFYTINLII
     PCVLITSLAI LVFYLPSDCG EKMTLCISVL LALTFFLLLI SKIVPPTSLD IPLIGKYLLF
     TMVLVTFSIV TTVCVLNVHH RSPSTHTMAS WVKECFLHKL PTFLFMKRPG LEVSLVRVPH
     PSQLHLATAD TAATSALGPT SPSNLYGSSM YFVNPVPAAP KSAVSSHTAG LPRDARLRSS
     GRFREDLQEA LEGVSFIAQH LESDDRDQSV IEDWKFVAMV VDRLFLWVFV FVCILGTMGL
     FLPPLFQIHA PSKDS
//
